Skip to content
Open access

Enhancement of antitumor activity through structural optimization of 2-(Benzylamino)-thieno[2,3-d]pyrimidin-4(3H)-ones

Aug 2026 · Medicinal Chemistry Research · Vol 35, pp. 1755 - 1773 · 0 citations · 54 references
Medicine

TL;DR

The obtained findings demonstrated potential of 2-benzylaminothienopyrimidin-4(3H)-ones as promising scaffolds for further development of anticancer agents.

Read PDF

Similar papers

Sep 2026

Synthesis, anticancer, and antioxidant activity study of some new 3-(4,6-dihydroxypyrimidin-2-yl) -2-(aryl)thiazolidin-4-ones

This study aims to synthesize a series of pyrimidine derivatives linked to active units and evaluate their anticancer and antioxidant activities. First, several Schiff bases were synthesized by the condensation of 2-aminopyrimidine- 4,6-diol with suitable aromatic aldehydes. Subsequently, Schiff bases were subjected to...

Q. A. Jaber · 0 citations
Open access Sep 2026

Design, synthesis, molecular docking and anticancer activity of novel N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives

Results suggest that the N-(4-(chlorodifluoromethoxy)phenyl)-1H-pyrrolo[2,3-b]pyridine-5-carboxamide scaffold is a useful template for designing selective BCR-ABL1-directed anticancer agents, with compound 9c as an encouraging lead for further optimisation and mechanistic studies.

Pradeep B. Bhise, Sandeep B. Bhise, Somnath Dasgupta et al. · 0 citations
Open access Aug 2026

DESIGN, SYNTHESIS, AND PRELIMINARY ANTIPROLIFERATIVE EVALUATION OF BENZIMIDAZOLE-1,3,4-OXADIAZOLE HYBRIDS SHOWING PREFERENTIAL ACTIVITY IN BREAST CANCER CELL LINES

Findings indicate that the benzimidazole-1,3,4-oxadiazole hybrid scaffold may provide a useful starting point for the development of breast cancer-oriented antiproliferative candidates.

Mahmut Gozelle, Şevval Yaman, Züleyha Arslan et al. · 0 citations
Sep 2026

Synthesis, Crystal Structure, DFT, MEP, FMOs, Hirshfeld Analysis and Antitumor Activity Assay of 4-[(4-Fluorophenyl)amino]-6-pentylpyrido[4,3-d]pyrimidin-5(6H)-one

The results demonstrated that the DFT-optimized molecular structure is in good agreement with the crystal structure measured by X-ray single-crystal diffraction, thereby validating the reliability of the theoretical calculations.

Wei Zeng, Run-Tao Guo, Lan Jin et al. · 0 citations
Open access Sep 2026

Pyrimidine- and furo[2,3-d]pyrimidine-isoxazole hybrids and their Re(i) tricarbonyl complexes with antiproliferative activity against hematological malignancies

Pyrimidine and furo[2,3-d]pyrimidine derivatives have emerged as promising anticancer agents that act through multiple mechanisms, including modulation of downstream signaling pathways such as a JAK2/STAT3 cascade. Herein, we report the synthesis of novel pyrimidine- and furo[2,3-d]pyrimidine-isoxazole hybrids via base...

Martina Piškor Benković, I. Ćorić, Leo Sačer et al. · 0 citations
Open access Aug 2026

Iodine-mediated 2,5-di(aryl/heteroaryl)-1,3,4-oxadiazoles: synthesis, and in vitro and in silico studies of anticancer and antifungal properties

The synthesis of a series of novel 2,5-di(aryl/heteroaryl)-1,3,4-oxadiazole derivatives using molecular iodine under basic conditions identifies 9b and 9g as promising lead 1,3,4-oxadiazole derivatives for further development as anticancer agents.

Thongolla Ramesha, T. Shenoy, U. V. Subba Reddy et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.